Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.